Compare FOSL & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOSL | BHST |
|---|---|---|
| Founded | 1984 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.9M | 137.1M |
| IPO Year | 1993 | N/A |
| Metric | FOSL | BHST |
|---|---|---|
| Price | $3.75 | $5.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 557.4K | 61.8K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,066,179,000.00 | $32,720,000.00 |
| Revenue This Year | N/A | $116.40 |
| Revenue Next Year | N/A | $55.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 45.88 |
| 52 Week Low | $0.86 | $4.72 |
| 52 Week High | $4.40 | $12.80 |
| Indicator | FOSL | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 59.42 | 38.32 |
| Support Level | $3.61 | $5.07 |
| Resistance Level | $3.93 | $5.43 |
| Average True Range (ATR) | 0.24 | 0.46 |
| MACD | -0.04 | 0.07 |
| Stochastic Oscillator | 58.50 | 15.89 |
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.